Evidence map›Paper›PMID 36091825›Full record

ReviewFrontiers in pharmacology2022

Essential Oils as Multicomponent Mixtures and Their Potential for Human Health and Well-Being.

Marek Bunse, Rolf Daniels, Carsten Gründemann, Jörg Heilmann, Dietmar R Kammerer, Michael Keusgen, Ulrike Lindequist, Matthias F Melzig, Gertrud E Morlock, Hartwig Schulz and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 82 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
82citing papers in PubMed, 4 pooled it
21.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

82 citing papers in PubMed, 4 syntheses or guidelines pooled it, 166 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Optimizing Antibacterial Essential Oil Blends fromFoods (Basel, Switzerland) · 2026
    Article
  18. Review
  19. Article
  20. Article

22 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 2 countries.

Marek BunseDepartment of Analytical Development and Research, WALA Heilmittel GmbH, Bad Boll, Germany.
Rolf DanielsDepartment of Pharmaceutical Technology, University of Tübingen, Tübingen, Germany.
Carsten GründemannTranslational Complementary Medicine, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Jörg HeilmannDepartment of Pharmaceutical Biology, University of Regensburg, Regensburg, Germany.
Dietmar R KammererDepartment of Analytical Development and Research, WALA Heilmittel GmbH, Bad Boll, Germany.
Michael KeusgenInstitute of Pharmaceutical Chemistry, Philipps-Universität Marburg, Marburg, Germany.
Ulrike LindequistInstitute of Pharmacy, Ernst-Moritz-Arndt-University Greifswald, Greifswald, Germany.
Matthias F MelzigInstitute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
Gertrud E MorlockInstitute of Nutritional Science, Chair of Food Science and TransMIT Center for Effect-Directed Analysis, Justus Liebig University Giessen, Giessen, Germany.
Hartwig SchulzConsulting & Project Management for Medicinal & Aromatic Plants, Stahnsdorf, Germany.
Ralf SchweiggertInstitute of Beverage Research, Chair of Analysis and Technology of Plant-Based Foods, Geisenheim University, Geisenheim, Germany.
Meinhard SimonInstitute for Chemistry and Biology of the Marine Environment, University of Oldenburg, Oldenburg, Germany.
Florian C StintzingDepartment of Analytical Development and Research, WALA Heilmittel GmbH, Bad Boll, Germany.
Michael WinkInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Wala Heilmittel (Germany) · DECarl von Ossietzky Universität Oldenburg · DEFreie Universität Berlin · DEHeidelberg University · DEHochschule Geisenheim University · DEPhilipps University of Marburg · DEUniversität Greifswald · DEUniversity of Basel · CHUniversity of Giessen · DEUniversity of Regensburg · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Essential oils (EOs) and their individual volatile organic constituents have been an inherent part of our civilization for thousands of years. They are widely used as fragrances in perfumes and cosmetics and contribute to a healthy diet, but also act as active ingredients of pharmaceutical products. Their antibacterial, antiviral, and anti-inflammatory properties have qualified EOs early on for both, the causal and symptomatic therapy of a number of diseases, but also for prevention. Obtained from natural, mostly plant materials, EOs constitute a typical example of a multicomponent mixture (more than one constituent substances, MOCS) with up to several hundreds of individual compounds, which in a sophisticated composition make up the property of a particular complete EO. The integrative use of EOs as MOCS will play a major role in human and veterinary medicine now and in the future and is already widely used in some cases,

Indexed as

antibiotic resistanceessentail oilsintegrative medicinemulticomponent mixturesphytotherapy

Identifiers

PMID36091825
PMCPMC9449585
OpenAlexW4293013330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.